Keep Memory Alive to Honor Neil Diamond at 24th Annual Power of Love Gala, March 7, 2020

  LAS VEGAS: Keep Memory Alive will honor legendary singer-songwriter and musician Neil Diamond at the 24th annual Power of Love® gala on Saturday, March 7, 2020, at the MGM Grand Garden Arena. Tickets are on sale now at keepmemoryalive.org/power-of-love-2020. Diamond, who announced his retirement from touring in 2018 after being diagnosed with Parkinson’s disease, … Read More

Cleveland Clinic Releases Fourth Installment of Annual Alzheimer’s Disease Drug Development Pipeline Report

Cleveland Clinic’s fourth annual analysis of Alzheimer’s disease drug development found that the pipeline has grown in the number and variety of agents being tested over the past year, while highlighting several advances in the field including new clinical trial designs, more detailed criteria for making a research diagnosis, and an increased use of biological … Read More

Cleveland Clinic Lou Ruvo Center for Brain Health Obtains Sole Investigational New Drug License for GE180 Tracer to Detect Neuroinflammation in the Brains of Those with Parkinson’s and Alzheimer’s Disease

Las Vegas: The Cleveland Clinic Lou Ruvo Center for Brain Health has obtained the only Investigational New Drug (IND) to be issued by the Federal Drug Administration to test the GE180 ligand tracer, an experimental diagnostic imaging tool used to detect neuroinflammation, in the brains of those with Parkinson’s and Alzheimer’s disease. Ligand tracers are … Read More

Cleveland Clinic Injects $17.8 Billion into Ohio’s Economy

Cleveland Clinic boosted the Ohio economy by $17.8 billion in 2016, according to the hospital system’s most recent economic impact report, “A Vital Force in Ohio’s Economy.” The activities of Cleveland Clinic – the second largest employer in Ohio – supported 119,720 Ohio jobs in 2016, representing more than $7.5 billion in total earnings. Those … Read More

Cleveland Clinic Analysis Finds that Drug Development in Alzheimer’s Still Inadequate

Cleveland Clinic’s third annual analysis of Alzheimer’s disease drug development reveals that drug development continues to be disappointingly slow. Researchers, however, are learning more about evolving targets in the pipeline, including a movement toward disease prevention and an emphasis in disease-modifying therapies. The paper, Alzheimer’s disease drug development: pipeline 2018, is based on the federal … Read More

Cleveland Clinic Provided $809 million in community benefit in 2016

In 2016 Cleveland Clinic provided $809 million in community benefit in Ohio, Nevada and Florida, a 17 percent increase over 2015. Community benefit is a measure of a hospital’s investment in its community through outreach programs, medical education, research, financial assistance, coverage of Medicaid shortfalls, and subsidized care. “As a non-profit academic medical center, we … Read More